T

Telemedycyna Polska SA
WSE:TMP

Watchlist Manager
Telemedycyna Polska SA
WSE:TMP
Watchlist
Price: 0.695 PLN 11.2% Market Closed
Market Cap: zł9.4m

P/S

0
Current
No historical data
Comparison unavailable

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
0
=
Market Cap
zł0
/
Revenue
0

Price to Sales (P/S) ratio shows how much investors pay for each dollar of a company`s sales. It`s calculated by dividing the company`s market value by its total revenue.

P/S
0
=
Market Cap
zł0
/
Revenue
0

Valuation Scenarios

Telemedycyna Polska SA is trading above its industry average

If P/S returns to its Industry Average (0.6), the stock would be worth zł0 (100% downside from current price).

Statistics
Positive Scenarios
0/2
Maximum Downside
-100%
Maximum Upside
No Upside Scenarios
Average Downside
100%
Scenario P/S Value Implied Price Upside/Downside
Current Multiple 0 zł0.7
0%
Industry Average 0.6 zł0
-100%
Country Average 1.1 zł0
-100%

Forward P/S
Today’s price vs future revenue

Not enough data available to calculate forward P/S

Peer Comparison

All Multiples
P/S
P/E
All Countries
Close

Market Distribution

Not Available
No Country distribution data available for this multiple

Telemedycyna Polska SA
Glance View

Market Cap
9.4m PLN
Industry
Health Care

Telemedycyna Polska SA engages in the provision of medical treatment. The company is headquartered in Katowice, Woj. Slaskie. The company went IPO on 2010-08-18. The company operates Kardiotele system which enables cardiologic care and checks such as electrocardiogram (EKG) through telephone connection. Kariotele is addressed to individuals, as well as to nursing homes and rehabilitation centers. As of December 31, 2011, the Company operated one wholly owned subsidiary, Centrum Nadzoru Kardiologicznego Kardiofon Sp. z o.o.

TMP Intrinsic Value
Not Available
T
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett